Cargando…
An injectable, in situ forming and NIR-responsive hydrogel persistently reshaping tumor microenvironment for efficient melanoma therapy
BACKGROUND: Melanoma is a highly aggressive form of skin cancer with increasing incidence and mortality rates. Chemotherapy, the primary treatment for melanoma, is limited by hypoxia-induced drug resistance and suppressed immune response at the tumor site. Modulating the tumor microenvironment (TME)...
Autores principales: | Zhang, Han, Hu, Liangshan, Xiao, Wei, Su, Yanqiong, Cao, Donglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659094/ https://www.ncbi.nlm.nih.gov/pubmed/37981704 http://dx.doi.org/10.1186/s40824-023-00462-y |
Ejemplares similares
-
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
por: Shin, Gi Ru, et al.
Publicado: (2021) -
Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel
por: Zhuang, Qiuyu, et al.
Publicado: (2023) -
In Situ Forming Injectable Thermoresponsive Hydrogels
for Controlled Delivery of Biomacromolecules
por: Dutta, Kingshuk, et al.
Publicado: (2020) -
In-situ forming injectable GFOGER-conjugated BMSCs-laden hydrogels for osteochondral regeneration
por: Ha, Mi Yeon, et al.
Publicado: (2023) -
In Situ Forming Injectable Hydrogel For Encapsulation Of Nanoiguratimod And Sustained Release Of Therapeutics
por: Ma, Zhenzhen, et al.
Publicado: (2019)